Cite
HARVARD Citation
de los Rios, C. et al. (2021). Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome. Therapeutic advances in gastroenterology. p. . [Online].